Subscribe To
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2023
― Screening closed for the Phase 3 REACH pivotal trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) ― ― Expect to report topline data for REACH in the fourth quarter of 2024 ― ― Interactions continue with the U.S. Food and Drug Administration (FDA) to resolve clinical hold for FTX-6058 in sickle cell disease (SCD) […] The post Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2023 appeared first on ForexTV...
Read More
Content Topics
Fulcrum
Therapeutics
Announces
Recent
Business
Highlights
Financial
Results for
Second
Quarter
Forex
Posted: Aug 3 2023, 11:01
Author Name: forextv
Views: 080748